Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Kardiologiia ; 28(4): 11-3, 1988 Apr.
Artigo em Russo | MEDLINE | ID: mdl-3392858

RESUMO

A study of 585 patients with acute myocardial infarction (285 with and 300 without cardiac arrest) showed the two groups to differ significantly in terms of clinical, laboratory and electrocardiographic findings. Resuscitation effectiveness depended upon the form of cardiac arrest (chi 2 = 209.25; p less than 0.001). A stable resuscitation effect (survival within and beyond 28 days after the onset of acute myocardial infarction) was achieved in 78.4% of cases of primary ventricular fibrillation, 24.0% of cases of secondary ventricular fibrillation, and 4.9% of asystolia cases. All cases of electromechanical dissociation were fatal. Long-term follow-up showed that 17.3% of patients with cardiac arrest and 21.9% of patients without cardiac arrest died over 4 years (p greater than 0.05).


Assuntos
Parada Cardíaca/terapia , Infarto do Miocárdio/mortalidade , Ressuscitação , Parada Cardíaca/etiologia , Humanos , Infarto do Miocárdio/reabilitação , Prognóstico , Fatores de Risco
2.
Kardiologiia ; 25(9): 59-61, 1985 Sep.
Artigo em Russo | MEDLINE | ID: mdl-2867244

RESUMO

One hundred patients with angina pectoris were studied to determine the antianginal effectiveness of senzit, fenigidin and trasicor. The calcium antagonists senzit and fenigidin were found to have high antianginal effect (44% and 78%, respectively) in patients with stable angina pectoris. It was found advisable to use the two drugs in combination with cardiac glycosides in patients with heart failure. A study showed the high antianginal effect of trasicor in postinfarction patients with refractory angina of effort.


Assuntos
Antagonistas Adrenérgicos beta/uso terapêutico , Angina Pectoris/tratamento farmacológico , Cálcio/antagonistas & inibidores , Fendilina/uso terapêutico , Nifedipino/uso terapêutico , Fenetilaminas/uso terapêutico , Propranolol/uso terapêutico , Idoso , Glicosídeos Cardíacos/administração & dosagem , Quimioterapia Combinada , Feminino , Fendilina/administração & dosagem , Humanos , Masculino , Pessoa de Meia-Idade , Infarto do Miocárdio/complicações , Infarto do Miocárdio/reabilitação , Nifedipino/administração & dosagem , Esforço Físico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA